Junko Maruyama - Concepedia

Author

Junko Maruyama

Also Known As

J MARUYAMA, J Maruyama, J. MARUYAMA, J. Maruyama, JUNKO MARUYAMA, Junichi Maruyama, Junko MARUYAMA, Junko Maruyama, Maruyama, J., Naoyuki Kuse

Publications

915

Citations

H-Index

Concepts

All Affiliations

Mie University Suzuka University of Medical Science The University of Tokyo Tokyo Metropolitan Komagome Hospital The University of Osaka

About

Junko Maruyama is an author at Mie University specializing in medicine, physiology, and pulmonary vascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	404
2	Public Health	6	6	232
3	Engineering	2	2	30
4	Business	1	1	17
5	Health Sciences	1	1	22

Junko Maruyama

Publications

793

Citations

H-Index

Page 1

	Year	Citations
A Nuclear Factor-κB Inhibitor Pyrrolidine Dithiocarbamate Ameliorates Pulmonary Hypertension in Rats Hirofumi Sawada, Yoshihide Mitani, Junko Maruyama, CHEST Journal Molecular PharmacologyHypertensionPulmonary Arterial HypertensionPulmonary CirculationLung Inflammation	2007	92
Cytokine Profiles of Macrophage Activation Syndrome Associated with Rheumatic Diseases Junko Maruyama, Shigeko Inokuma The Journal of Rheumatology	2010	86
Deficiency of tenascin C attenuates allergen‐induced bronchial asthma in the mouse Hiroki Nakahara, Esteban C. Gabazza, Hajime Fujimoto, European Journal of Immunology AsthmaInflammatory Lung DiseaseLung InflammationAllergy MedicineImmunology	2006	63
Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats Junko Maruyama, Kazuo Maruyama American Journal of Physiology-Heart and Circulatory Physiology HypertensionEndothelial CellsNitric OxidePulmonary HypertensionOxidative Stress	1994	57
Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases Keiichi Yamanaka, Takehisa Nakanishi, Hiromitsu Saito, PLoS ONE	2014	53
Experience of Peripherally Inserted Central Venous Catheter in Patients with Hematologic Diseases Yoshinori Hashimoto, Takanori Fukuta, Junko Maruyama, Internal Medicine	2017	40
Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats Junko Maruyama, Kazuo Maruyama, Yoshihide Mitani, American Journal of Physiology-Heart and Circulatory Physiology HypertensionRight Ventricular HypertrophyPulmonary HypertensionPharmacotherapyPulmonary Pharmacology	1997	33
Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis Yasuhiro Sawada, K Onoda, Junko Maruyama, Cardiovascular Research	2007	32
The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension Masato Morikawa, Yoshihide Mitani, Katarina Holmborn, Science Signaling	2019	32
Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis Kazuyoshi Ishigaki, Junko Maruyama, Noboru Hagino, Rheumatology International Prognostic FactorSkin UlcerPathologyClinical DermatologyContact Dermatitis	2013	30

Page 1